Geoff Carr Fellowship
Geoff Carr Lupus Fellowship RFA 2024-2025 (1) This annual Fellowship allows for a rheumatologist to receive advanced training in lupus by submitting a research project in lupus combined with clinical training at an […]
Public Funding For ANCA and Anti-CCP Tests Effective September 25, 2023!
In thanks to the hard work of many individuals, effective September 25, 2023, ANCA and anti-CCP tests will be funded within the Community Access Pilot program. Criteria has also been established that defines who can […]
Apply for an ORADE Grant!
The mandate of the Ontario Rheumatology Association Development and Education Committee (ORADE) is to support ORA members and AHP colleagues in their professional development by offering educational grants. The grants are available to ORA members and […]
Position Statement – Biosimilar Tiering
The ORA has developed a position statement on biosimilar tiering. Please visit it here: Biosimilar Tiering […]
Call for Abstracts: 2023 Lupus Ontario Annual Symposium
The deadline to submit an abstract for the 2023 Lupus Ontario Annual Symposium is October 21! For more information, please visit this link: Lupus Ontario Call for Abstracts […]
Applications Are Now Being Accepted for a William Bensen MoC Grant
The deadline to apply for a William Bensen MOC Initiative Grant is September 1, 2023. This year, we will be awarding 1 grant to a successful applicant who will receive up to a maximum of […]
Award Recipients Announced!
Congratulations to the following members on well-deserved award recognition: Distinguished Members Award: Dr. Wes Fidler Dr. Jody Lewtas Dr. Alfred Cividino Dr. Vincent Mak (Posthumous Award) Early Career Rheumatologist Dr. Sahil Koppikar […]
CPSO Removes Barriers for Internationally Educated Physicians
The full article is available here: https://www.cpso.on.ca/News/News-Articles/CPSO-Removes-Barriers-for-Internationally-Educated […]
Holiday Message From Dr. Felix Leung
Dear Members of the Ontario Rheumatology Association, As the holiday season approaches, I wanted to take a moment to wish you all a happy and safe holiday season. I hope that you are […]
Biosimilar Transition Policy Announcement in Ontario
On December 20, 2022 the Ontario Ministry of Health announced that effective March 31, 2023, a transition policy will be implemented to expand the use of biosimilar medicines within the public drug program. […]
